Analyst Reco. Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Real-time Estimate Cboe BZX Other stock markets 16:20:45 29/04/2024 BST			5-day change	1st Jan Change
10.52 ^USD	+1.11%		-5.14%	-17.41%

03-25	Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	MT
02-27	Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Truist Securities Adjusts Price Target on Treace Medical Concepts to $16 From $12, Keeps Buy Rating	12-22	MT
UBS Adjusts Price Target on Treace Medical Concepts to $17 From $24, Maintains Buy Rating	11-13	MT
Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $14 From $30, Maintains Overweight Rating	11-13	MT
Truist Adjusts Price Target on Treace Medical Concepts to $12 From $17, Maintains Buy Rating	11-10	MT
UBS Initiates Treace Medical Concepts With Buy Rating, Price Target is $24	29/09/23	MT
BTIG Adjusts Treace Medical Concepts' Price Target to $27.50 From $32, Keeps Buy Rating	28/08/23	MT
Stephens Adjusts Price Target on Treace Medical Concepts to $25 From $27, Keeps Equalweight Rating	10/08/23	MT
Truist Securities Adjusts Price Target on Treace Medical Concepts to $30 From $33, Maintains Buy Rating	09/08/23	MT
Truist Starts Treace Medical Concepts at Buy With $33	01/05/23	MT
BTIG Adjusts Price Target on Treace Medical Concepts to $32 From $29, Maintains Buy Rating	17/04/23	MT
Stephens Starts Treace Medical Concepts at Equalweight With $26 Price Target	11/04/23	MT
Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $30 From $28, Maintains Overweight Rating	08/03/23	MT
Morgan Stanley Adjusts Treace Medical Concepts' Price Target to $28 from $23, Maintains Overweight Rating	11/10/22	MT
BTIG Raises Price Target on Treace Medical Concepts to $28 From $23, Keeps Buy Rating	21/09/22	MT
Stifel Nicolaus Adjusts Treace Medical Concepts Price Target to $27 From $24, Maintains Buy Rating	21/09/22	MT
Stifel Nicolaus Adjusts Price Target for Treace Medical Concepts to $24 From $21, Maintains Buy Rating	10/08/22	MT
Stifel Lowers Treace Medical Concepts' Price Target to $21 From $32, Maintains Buy Rating	18/07/22	MT
Morgan Stanley Lowers Treace Medical Concepts' Price Target to $22 From $26, Maintains Overweight Rating	15/07/22	MT
BTIG Initiates Treace Medical Concepts at Buy, Sets Price Target at $22	12/05/22	MT
Stifel Adjusts Treace Medical Concepts' Price Target to $32 From $37, Keeps Buy Rating	04/03/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Analyst Reco.

Filters